Clinical Trials
6 trialsNCT02688036 2026-05-29
Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3 Completed
NCT05500391 2026-03-18
SUR-CAN
Centre Oscar Lambret
Phase 2 Recruiting
NCT02721732 2026-01-29
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT03333616 2026-01-21
Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
Dana-Farber Cancer Institute
Phase 2 Active not recruiting
NCT07206563 2025-10-03
Penfluridol for Relapsed/Refractory Small Cell Cancers
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1/2 Not yet recruiting
NCT07161882 2025-09-16
SAFRO2202
Société Algérienne de Formation et de Recherche en Oncologie
Recruiting